SJS Investment Consulting’s Cidara Therapeutics CDTX Stock Holding History

SJS Investment Consulting’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1	Closed	-$221	–	2482
2025 Q4	$221	Buy	+1	New	+$162	﹤0.01%	1777

SJS Investment Consulting's CDTX Position: Q1 2026 in Review

SJS Investment Consulting sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 1 share — an estimated $221 sold.

SJS Investment Consulting first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $221 in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

SJS Investment Consulting reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
SJS Investment Consulting sold 1 Cidara Therapeutics share in Q1 2026, an estimated $221.
SJS Investment Consulting first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
SJS Investment Consulting's Cidara Therapeutics position peaked at $221 in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on SJS Investment Consulting's 13F filing for Q1 2026, filed 23 Apr 2026.